ECJ guidance on the operation of the mutual recognition procedure
16-Dec-2008 | Life Sciences & Healthcare
Lawyers Helen Cline
A Member State being asked to approve a generic product under the mutual recognition procedure (MRP) has only limited powers to challenge the approval granted by another Member State, says the ECJ in its recent decision in Case 452/06 R (on the application of Synthon BV) v Licensing Authority.
For the full text of the decision please click here
For the full article please click here
